Related Experiment Video
Updated: Feb 12, 2026

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer
Catherine M Shachaf1, Andrew M Kopelman, Constadina Arvanitis
1Division of Medical Oncology, Department of Medicine, Stanford University, California 94305, USA.
Abstract:
Hepatocellular carcinoma is generally refractory to clinical treatment. Here, we report that inactivation of the MYC oncogene is sufficient to induce sustained regression of invasive liver cancers. MYC inactivation resulted en masse in tumour cells differentiating into hepatocytes and biliary cells forming bile duct structures, and this was associated with rapid loss of expression of the tumour marker alpha-fetoprotein, the increase in expression of liver cell markers cytokeratin 8 and carcinoembryonic antigen, and in some cells the liver stem cell marker cytokeratin 19. Using in vivo bioluminescence imaging we found that many of these tumour cells remained dormant as long as MYC remain inactivated; however, MYC reactivation immediately restored their neoplastic features. Using array comparative genomic hybridization we confirmed that these dormant liver cells and the restored tumour retained the identical molecular signature and hence were clonally derived from the tumour cells. Our results show how oncogene inactivation may reverse tumorigenesis in the most clinically difficult cancers. Oncogene inactivation uncovers the pluripotent capacity of tumours to differentiate into normal cellular lineages and tissue structures, while retaining their latent potential to become cancerous, and hence existing in a state of tumour dormancy.
Insights
Inactivating the MYC oncogene causes invasive liver cancers to regress by differentiating tumor cells into normal liver cells. Reactivating MYC restores cancer, revealing a dormant state in hepatocellular carcinoma treatment.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Hepatocellular carcinoma (HCC) presents significant clinical treatment challenges due to its refractory nature.
- The MYC oncogene plays a critical role in the development and progression of various cancers, including HCC.
Purpose of the Study:
- To investigate the therapeutic potential of MYC oncogene inactivation in treating invasive liver cancers.
- To elucidate the cellular and molecular mechanisms underlying tumor regression and dormancy following MYC inactivation.
Main Methods:
- Inactivation of the MYC oncogene in a liver cancer model.
- In vivo bioluminescence imaging to monitor tumor cell behavior.
- Analysis of cell differentiation markers (alpha-fetoprotein, cytokeratin 8, carcinoembryonic antigen, cytokeratin 19).
- Array comparative genomic hybridization (aCGH) to assess genomic stability and clonal origin.
Main Results:
- MYC inactivation induced sustained regression of invasive liver cancers.
- Tumor cells differentiated into hepatocytes and biliary cells, forming bile duct structures.
- Differentiation was marked by altered expression of specific tumor and liver cell markers.
- MYC-inactivated cells entered a dormant state, retaining their neoplastic potential.
- MYC reactivation immediately restored neoplastic features, with cells being clonally derived from original tumor cells.
Conclusions:
- Inactivation of the MYC oncogene is a viable strategy for inducing regression in hepatocellular carcinoma.
- Oncogene inactivation can reverse tumorigenesis by promoting tumor cell differentiation and dormancy.
- This approach highlights the potential to exploit the pluripotent capacity of tumor cells for cancer therapy, even in difficult-to-treat cancers.
More Related Videos
08:48An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation
Published on: June 30, 2015
09:14An In Vitro System to Study Tumor Dormancy and the Switch to Metastatic Growth
Published on: August 11, 2011
Related Concept Videos
Logarithmic Differentiation
Implicit Differentiation
X-Inactivation
Induced Pluripotent Stem Cells
Activation and Inactivation of G Proteins
Combinatorial Gene Control
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...